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AbstrACt
Objectives To describe the novel concept of, and methods 
for developing, a ‘universal-reporter’ outcome measure 
(UROM); a single questionnaire for completion by patients 
and/or healthcare professionals (HCPs) when views on the 
same subject are required.
Design A mixed methods study with three phases—
phase I: identification of relevant content domains from 
existing clinical tools, patient questionnaires and in-
depth interviews with multistakeholders; phase II: item 
development using a novel approach that considered plain 
language in conjunction with medical terminology; and 
phase III: pretesting with multistakeholders using cognitive 
interviews.
setting A case study in surgical wound assessment 
undertaken in two UK hospital trusts and one university 
setting.
Participants Patients who had recently undergone 
general abdominal surgery and healthcare professionals 
involved in post-surgical wound care.
results Phase I: In the example case study, 19 relevant 
content domains were identified from two clinical tools, 
two patient questionnaires and 19 multistakeholder 
interviews (nine patients, 10 HCPs). Phase II: Domains 
were operationalised into items and subitems (secondary 
components to collect further information, if relevant). 
The version after pretesting had 16 items, five of which 
included further subitems. Plain language in conjunction 
with medical terminology was applicable in nine (27%) 
items/subitems. Phase III: Pretesting with 28 patients 
and 14 HCPs found that the UROM was acceptable to 
both respondent groups. An unanticipated secondary 
finding of the study was that the combined use of plain 
language and medical terminology during questionnaire 
development may be a useful, novel technique for 
evaluating item interpretation and thereby identifying items 
with inadequate content validity.
Conclusion UROMs are a novel approach to outcome 
assessment that are acceptable to both patients and HCPs. 
Combining plain language and medical terminology during 
item development is a recommended technique to improve 
accuracy of item interpretation and content validity during 
questionnaire design. More work is needed to further 
validate this novel approach and explore the application of 
UROMs to other settings.
bACkgrOunD
Research often requires views from different 
stakeholders on the same subject. Reasons 
may be to combine different stakeholder 
responses to obtain comprehensive informa-
tion to better answer the research question. 
Other reasons may be to compare stake-
holder responses and explore any similari-
ties or differences in perspectives, opinions 
or behaviours. Alternatively, there may be 
logistical reasons for obtaining views from 
different stakeholders to enable important 
data to be collected irrespective of who is 
available to provide it. In a clinical trial, for 
strengths and limitations of this study
 ► A novel approach to outcome assessment is de-
scribed, comprising the use of plain language along-
side medical terminology in questionnaire items to 
develop a single measure for completion by patients 
and/or healthcare professionals.
 ► Multiple stakeholders were considered in all phases 
of development of the new universal-reporter out-
come measure (UROM).
 ► Combined use of plain language and medical ter-
minology in items presents a novel technique for 
evaluating item interpretation and improving content 
validity during questionnaire development.
 ► Evaluation of this novel method is limited to the 
findings from a single case study. Further work is 
warranted to explore the applicability of UROMs to 
other settings.
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Table 1 Phases of UROM development
Established methods for outcome 
measure development Adapted/novel methods relevant to UROM development
Phase I Identification of content domains Emphasis on using a multistakeholder perspective to identify domains of importance.
Phase II Item construction A multistakeholder approach considering plain language in conjunction with medical 
terminology.
Phase III Pretesting and evaluation of content validity Cognitive interviews with multiple stakeholders.
UROM, universal-reporter outcome measure.
example, the frequency and severity of symptoms and 
adverse events might be self-reported by the patient and/
or judged by an observer, such as a healthcare profes-
sional (HCP).1 2 In these situations, assessment tools 
and questionnaires are usually developed separately for 
use by specific stakeholder groups. Consequently, two 
different tools/questionnaires that intend to measure 
the same construct (concept) may use different termi-
nology to suit the target audience. In the assessment of 
wounds for surgical site infection, for example, there are 
tools for clinical staff that use medical terminology such 
as ‘purulent drainage’ and ‘spontaneous dehiscence’. 
Alternatively, separate patient-completed question-
naires use plain language descriptions asking patients, 
for example, about ‘discharge or leakage of fluid’ and 
whether the ‘edges of the wound separated or gaped 
open’.
While separate stakeholder-specific tools may intend to 
measure the same constructs, uncertainty remains about 
whether this is achieved in practice. Evidence suggests 
that even minor alterations to item (question) wording 
can lead respondents to draw on different sources of 
information, subsequently affecting their responses.3 4 It 
is likely, therefore, that the use of different stakehold-
er-specific terminology in separate tools for patients and 
for HCPs that intend to measure the same construct 
may introduce a degree of variation in the way that they 
are interpreted and subsequently the response that is 
provided. Specifically, differential understanding of 
items between individual respondents or stakeholder 
groups can compromise the measure’s content validity 
or degree to which the content adequately reflects the 
construct being measured. This can have implications 
for drawing accurate conclusions when combining or 
comparing data collected from different stakeholder 
groups. Equitable interpretation of items by different 
respondents is therefore essential to ensure that the 
data collected by the separate measures are accurate and 
valid. It is hypothesised that developing a universal-re-
porter outcome measure (UROM) which uses a single 
set of terminology to collect data from either patients 
and/or HCPs may reduce variation in interpretation and 
thereby optimise the content validity of the measure. 
This study introduces the concept and method for devel-
oping a UROM, illustrated within a case study of surgical 
wound assessment.
MethODs
Case study: development of an outcome measure for surgical 
site infection (ssI)
The concept of a UROM originated as a solution to 
a problem within a feasibility study of surgical wound 
assessment. The feasibility study was performed to 
explore whether it would be possible to conduct a large 
randomised controlled trial (RCT) of different wound 
dressing strategies. The proposed primary outcome of 
the main RCT was surgical site infection (SSI) at 30 days 
post-surgery.5 Assessment of SSI at this timepoint would 
typically be after the patient had been discharged from 
hospital and was recovering at home. At the time of 
the feasibility study, separate stakeholder-specific tools 
for evaluating surgical wounds to assess SSI were avail-
able for HCPs and for patients though they had several 
limitations.6–10 The clinical tools for HCPs to complete, 
for example, were designed for use while patients were 
still in hospital, predominately used medical terminology 
and were complex to complete.6 8 The questionnaires 
for patients were developed from a clinical perspec-
tive, did not involve patients in their development and 
had not been formally validated.7 9 One aim of the feasi-
bility study, therefore, was to develop and validate an 
outcome measure to assess wounds for infection that was 
suitable for use both in-hospital after the patient had 
been discharged. While it would have been possible to 
develop two separate stakeholder-specific measures, it 
was recognised that this may compromise the validity with 
which the construct of SSI was measured. A single UROM 
to evaluate surgical wounds, suitable for completion by 
patients or HCPs, was therefore developed.
Development of the urOM
The UROM was developed using established methods 
for developing new outcome measures11 12, adapted to 
address specific issues relevant to developing a 'universal' 
measure for patient and/or HCP completion (table 1). 
The following sections provide a brief description of these 
unique considerations and adapted methods, drawing 
on the surgical wound case study as an example. A full 
description of the development and evaluation of the 
surgical wound outcome measure (including assessments 
of reliability, a comparison of patient and HCP responses 
and clinical validity) has been published elsewhere13 14 
and is outside the scope of this paper.
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box 1 example item showing plain language with 
medical terminology in parentheses
Was there redness spreading away from the wound? (erythema/
cellulitis)
box 2 example item showing first-person and third-
person narrative
Has your wound been drained? (drainage of pus/abscess)
Has the wound been drained? (drainage of pus/abscess)
Phase I: identification of content domains using a multistakeholder 
perspective
The first phase in the development of any new measure-
ment instrument typically involves the identification of 
important content domains (ie, areas of interest poten-
tially relevant to include in the new tool). Typical sources 
include the existing literature and interviews with key 
stakeholders to elicit expert opinion and experience.12 
The focus of the UROM development was to consider 
patient and HCP perspectives together to identify 
domains of importance to either or both stakeholders for 
consideration to include in a single, universal tool.
In the case study, health domains (defined as the 
sign, symptom or wound care intervention relevant to 
SSI assessment and management) important to patients 
and HCPs for possible inclusion in the new SSI measure 
were identified using existing guidelines for question-
naire development.11 15 First, a content analysis of the two 
most commonly used existing clinical tools identified in 
a previous systematic review,16 and their two associated 
patient questionnaires, was undertaken. In addition, 
in-depth interviews with 19 stakeholders were conducted; 
nine patients who had experience of wound infection 
and 10 HCPs involved in post-surgical care. Details of the 
existing tools, the methods for analysing their content 
and the interview sampling strategy and data collection 
have previously been reported.13 Importantly for the 
UROM, data from the analysis of existing tools and inter-
views were combined to provide a list of all the domains 
considered to be relevant to SSI assessment, irrespec-
tive of whether the source was from a patient’s and/or a 
HCP’s perspective.
Phase II: item construction using a multistakeholder approach; 
considering plain language in conjunction with medical 
terminology
The second phase in the development of a new measure-
ment instrument usually involves the conversion or ‘opera-
tionalisation’ of domains (identified in phase I) into items 
for a questionnaire. For the UROM, a novel approach was 
applied to item construction; using both plain language 
and medical terminology wherever possible. The reason 
for doing this initially was to use language that was under-
stood by, and was familiar to, each stakeholder group, 
to facilitate easy and timely completion of the outcome 
measure.
In the case study, the list of important SSI domains 
identified in phase I were considered for inclusion in 
the UROM. Domains considered to be unsuitable for 
patient report were excluded. Item construction was 
performed by four members of the case study team (JMB, 
RM, TM, BR), experts in the design and use of question-
naires including patient-reported outcome measures and 
professionals in the clinical field. First, plain language 
was used to describe the SSI domain in a clear and unam-
biguous way. Language was targeted for a lay audience 
without technical or medical terms, following standard 
recommendations.12 15 17 Next, medical terminology (if 
it existed) relating to the SSI domain was included in 
parentheses at the end of the item. An example is illus-
trated in box 1.
Response categories took the form of either a binary 
yes/no response or an ordinal scale (initially a five-point 
scale ‘not at all’, ‘a little’, ‘moderately’, ‘quite a bit’ and 
‘very much’) as appropriate to the individual item. The 
remaining structure and layout of the questionnaire 
was designed to be simple, clear and straightforward for 
patients and/or HCPs to complete, in accordance with 
established guidelines. The UROM was produced in two 
formats. One format was a paper-copy questionnaire to 
post to patients after leaving hospital. The other format 
was a paper-copy case report form for HCPs to complete 
when conducting observer wound assessments either on 
the telephone or face to face as part of the wider feasi-
bility study. Items and response categories were identical. 
The only minor difference was the use of first-person or 
third-person narrative, necessary for whether the tool was 
to be completed by a patient or an observer (box 2).
Phase III: pretesting and evaluation of content validity: cognitive 
interviews with multiple stakeholders
The third phase in the development of any new measure-
ment instrument involves pretesting with a sample of 
participants from the target population. Asking potential 
recipients to complete early drafts of a new measurement 
instrument is critical for testing understanding, interpre-
tation and identifying potential problems with its comple-
tion and use. Cognitive interviews are a valuable technique 
used during pretesting to examine content validity and 
ensure that items are comprehended as intended.12 18 
Pretesting of the case study outcome measure has previ-
ously been described in detail.13 Methods of specific rele-
vance to development of the UROM are emphasised and 
expanded below.
Participants and recruitment
In the case study, both patients and HCPs were invited to 
take part in cognitive interviews to pretest early versions 
of the measure. Patients were those who had recently 
undergone general abdominal surgery, identified and 
approached by research nurses/members of the study 
team in two UK hospital trusts. HCPs were those involved 
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Table 2 Identified domains of importance for inclusion in 
the case study UROM for surgical wound assessment
Domain relevant to SSI 
assessment
Existing tool
Patient 
questionnaire(s)
Clinical 
tool(s)
1. Wound healing ✓ x
2. Wound heat ✓ ✓
3. Wound redness ✓ ✓
4. Wound discharge ✓ ✓
5. Layers separating—
spontaneous
✓ ✓
6. Wound swelling ✓ ✓
7. Wound pain ✓ ✓
8. Fever x ✓
9. Contact with healthcare 
professional
✓ x
10. Dressing needed ✓ x
11. Antibiotics needed ✓ ✓
12. Layers separating—
deliberate
x ✓
13. Hospital admission ✓ x
14. Drainage needed x ✓
15. Wound cleaning ✓ ✓
16. Abscess ✓ ✓
17. Microbiology ✓ ✓
18. Prolonged hospital stay x ✓
19. Smell* x x
*Identified from stakeholder interviews.
SSI, surgical site infection; UROM, universal-reporter outcome 
measure.
in post-surgical care, identified from the same hospital 
trusts and from the authors’ university institution. Written 
information describing the study in detail was provided 
to all participants. Contact details of interested partici-
pants were passed on to members of the study team and 
followed up by telephone or email to further discuss the 
study, answer questions and arrange an interview. Inter-
views were conducted by two researchers (RM and TM) 
between January and August 2015. Written consent was 
obtained prior to each interview.
Cognitive interviews
Individual face-to-face cognitive interviews were 
conducted with participants to explore the overall accept-
ability, suitability and comprehensibility of the early 
versions of the UROM. The primary aim of the interviews 
was to examine the suitability of the UROM as an outcome 
measure for SSI. Specific objectives were to refine aspects 
of the questionnaire, including the layout, item phrasing, 
instructions and response categories. Additionally, and 
of specific relevance to development of a UROM, inter-
views explored views on items that included both plain 
language and medical terminology.
Participants were shown the questionnaire and asked 
to complete the items relating to their current experi-
ence (patients) or a recent or hypothetical patient case 
(HCPs). Participants were asked to vocalise their thoughts 
as they read and responded to each item using a ‘think 
aloud’ technique.18 Completion of the questionnaire was 
observed by the researcher who then used probing ques-
tions to explore the participants’ thoughts in more depth. 
Interpretation, accuracy and general opinions on the use 
of medical terminology alongside plain language in the 
questionnaire were sought. Question probes, for example, 
asking HCPs “Is (the plain language) a suitable descrip-
tion of the medical term?” were used to explore the accu-
racy of the item for measuring the intended underlying 
construct. Areas for investigation and specific items for 
discussion were identified and evolved throughout the 
course of interviews. Revisions were made to the provi-
sional draft and new versions tested in subsequent inter-
views with new participants until findings indicated that 
no further revisions were required.
Data analyses
Interviews were audio-recorded and written up in 
descriptive memoranda summarising key findings and 
suggestions for improvements to the questionnaire. 
Selected relevant quotations were transcribed verbatim. 
Interviews, analyses and modifications to the question-
naire were performed as an iterative process so that 
revisions to the questionnaire could be explored in 
subsequent interviews. Two researchers (RM and TM) 
independently conducted and summarised interviews, 
cross-checking approximately 25% of audio-recordings 
and memoranda to maximise rigour and reliability of 
the findings.19
Patient and public involvement
Patients and members of the public were involved 
throughout the study. Two patient and public represen-
tatives were included on the study steering committee. A 
meeting was held with a group of patients to discuss the 
design and conduct of the study and to refine patient-
facing study documents.
results
Phase I: identification of content domains using a 
multistakeholder perspective
In the case study, 19 relevant content domains (covering 
SSI signs, symptoms and wound care interventions) were 
identified from the existing tools and in-depth interviews 
(table 2). Of these 19 domains, 18 were identified from 
at least one of the existing clinical tools and/or patient 
questionnaires and were supported by interview data. 
One domain (smell) was not identified in any existing 
tools but was found to be important in interviews with 
both patients and HCPs.
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Table 3 Participant demographics and interview duration
Number of participants 
(total n=42)
Patients, n (%) 28 (66.7)
HCPs, n (%) 14 (33.3)
Age, years (%)
  21–30 1 (2.4)
  31–40 9 (21.4)
  41–50 5 (11.9)
  51–60 9 (21.4)
  >60 18 (42.9)
Male, n (%) 21 (50.0)
Clinical expertise*
  General practitioner 3 (21.4)
  Hospital/Research nurse/
midwife
4 (28.6)
  Practice/Community nurse/
midwife
3 (21.4)
  Surgical trainee 4 (28.6)
Surgery type,† n (%)
  Caesarean section 3 (10.7)
  Upper GI 9 (32.1)
  Lower GI 10 (35.7)
  Hernia repair 6 (21.4)
Duration of interview, min
  Median (range) 25 (13–52)
*HCP participants only.
†Patient participants only.
GI, gastrointestinal; HCP, healthcare professional.
Phase II: item construction using a multistakeholder 
approach; considering plain language in conjunction with 
medical terminology
Seventeen of the 19 domains identified in phase I were 
developed into items for the first draft of the UROM. Two 
domains were excluded (microbiology and prolonged 
hospital stay) as they were considered unsuitable for 
patient report, and information could more reliably be 
obtained through other sources (eg, hospital records). 
All items were intended to be completed by all respon-
dents, with some items having secondary components 
(subitems) to collect further information, where rele-
vant. For example, if a participant responded to an item 
indicating that a symptom was present, further questions 
captured more details about that symptom.
The first draft of the UROM prior to pretesting included 
13 items, of which six included secondary subitems to 
collect further information. Eight medical terms were 
included in parentheses after the plain language either 
in the items or secondary subitems. It was not appli-
cable to include medical terminology in the remaining 
items because a medical description did not exist for 
the construct being addressed; for example, “Has the 
wound been smelly?”. In the first draft, eight items had 
ordinal response categories and five items had binary 
yes/no response options. Responses of ‘don’t know’ were 
also included to explore whether participants required 
this option and identify potentially problematic items to 
answer.
Phase III: pretesting and evaluation of content validity: 
cognitive interviews with multiple stakeholders
Forty-two cognitive interviews (with 28 patients and 14 
HCPs) were conducted. Participant characteristics and 
interview duration are summarised in table 3.
Detailed findings from the pretesting phase of the 
case study SSI outcome measure have previously been 
reported.13 Findings of particular relevance to UROM 
design are described in detail below.
Modifications to the UROM during pretesting
Throughout pretesting and the iterative process of inter-
views and revisions, the UROM was modified eight times. 
The final version after pretesting included 16 items for 
assessing SSI, with five having secondary subitems to 
collect further information. Nine medical terms were 
included in parentheses at the end of items/subitems 
(see online supplementary file 1).
General modifications (not specific to UROM design) 
included revision of the ordinal response categories 
from a five-point to a four-point scale (‘not at all’, ‘a 
little’, ‘quite a bit’ and ‘a lot’) because a middle cate-
gory of ‘moderately’ was found to be uninformative. 
The filter question at the beginning of the measure 
(“Have you had any problems with the healing of your 
wound(s)?”) was also dropped because data indicated 
that participants’ answers to this filter question were 
often not concordant with their subsequent responses to 
subsequent items (eg, participants responded that they 
had no problems with wound healing but went on to 
report experiencing symptoms of problems with wound 
healing). General changes also included restructuring 
some items, for example, changing some secondary 
subitems to standalone items to minimise errors and 
reduce missing data.
Several changes were made to the provisional measure 
of specific relevance to UROM design. Most changes 
related to the use of plain language in conjunction 
with medical terminology. For example, one medical 
term (calor) was dropped as interviews revealed it was 
not a term that was used in current practice. Another 
medical term (spontaneous dehiscence) was added to 
an item where previously no medical description had 
been considered. Detail explaining the reason for this 
is provided below. In another item, one term (dressing) 
that was initially included in the plain language descrip-
tion was later moved to the end of the item in parentheses 
because interviews revealed that it was less understood by 
a lay audience than initially expected.
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box 3 Acceptability of items combining plain language 
and medical terminology
Participant: “I just skipped over it… I did say ‘What’s that?’ but it 
didn’t concern me because I could answer the question… I did 
make the comment of what [is that] but I didn’t worry about it and I 
just went on to the next bit.” Patient participant, 1107
Participant: “I was… you know… interested [in the medical terms]. 
I didn’t look at all of it… um, a couple I thought was interesting 
because it was Latin. That’s what I thought. And also spontaneous 
dehiscence… I thought, gosh… so yeah I found it quite interesting.”
Interviewer: “Did you find them [medical terms] confusing?”
Participant: “No… For instance that first one… I don’t think I even 
saw…” Patient participant, 1104
Participant: “If I was… on my own receiving this I am a bit of a 
google searcher so I would probably have looked them up.” Patient 
participant, 2030
box 4 Improved understanding and interpretation of 
items
Item: Was there redness spreading away from the edges of the wound? 
(erythema and cellulitis)
Participant: “In that first one [item], because I was describing the 
redness under the skin – more deeper redness, purple - when I 
read that first question, it was the fact that I had some idea of what 
erythema and cellulitis are… I thought, well it wasn’t those…but 
ended up saying a little because of the redness… it probably was 
erythema… but I wasn’t sure.”
Interviewer: “And if we didn’t have that erythema and cellulitis in 
there?…”
Participant: “Yeh, I would then have probably thought… that it was 
[asking about] that [bruising]… but because I recognised those [er-
ythema and cellulitis]… I think I know more or less what those two 
things are.” Patient participant, 1081
Acceptability of UROMs and items combining plain language and 
medical terminology
In general, neither patients nor HCPs reported signifi-
cant concerns with the inclusion of medical terminology 
alongside plain language within the same item. Some 
patients reported that they found the medical terms inter-
esting and educational. Other patients reported that they 
found the plain language alone sufficient for compre-
hension and therefore ignored or did not notice the 
medical terms (box 3). Concerns that medical terms may 
cause patients anxiety was raised in interviews with HCPs, 
although this was not supported by data from interviews 
with patients. One patient referred to the use of the 
Internet to look up medical terms but did not express any 
concerns about doing so (box 3).
Improved understanding and interpretation of items
An unanticipated secondary unexpected finding of the 
study was that the combined use of plain language and 
medical terminology may be a useful, novel technique for 
evaluating item understanding and improving item inter-
pretation during the process of developing the measure. 
Findings from the pretesting interviews indicated that the 
inclusion of a medical term alongside plain language in 
an item directly affected the way that participants inter-
preted and subsequently responded to items, by facili-
tating their understanding of the item. One participant, 
for example, explained how the presence of the medical 
term improved their understanding of the item, thereby 
enabling them to respond more accurately. This partici-
pant reported that they would have interpreted the item 
differently, and therefore responded differently, had the 
medical term not been included (box 4).
Identification of items with inadequate content validity
Directly related to the finding that the use of plain 
language and medical terminology may improve partic-
ipants’ understanding and interpretation of items, the 
combined use of plain language and medical termi-
nology during item development was found to be a 
useful technique to maximise the content validity of the 
outcome measure. The tandem use of medical termi-
nology and plain language identified several items that 
were ambiguous or insufficiently reflected the construct 
that was intended to be measured. For example, it became 
apparent during interviews that some participants who 
read the plain language were interpreting an item differ-
ently to others who were also reading and understanding 
the medical terminology (box 5). In this example, quotes 
from patient participants demonstrated that the item was 
not being interpreted as intended, while quotes from 
the HCP participants indicated that the plain language 
description was not an adequate reflection of the medical 
terminology. This led to the item being modified to 
include more detail in the plain language description.
In addition to the finding that using both plain language 
and medical terminology from the outset of item develop-
ment may improve the content validity of the outcome 
measure, there was some evidence to suggest that adding 
medical terminology to an item that had initially been 
written using only plain language may also maximise 
content validity. For example, interviews indicated that 
the plain language item “Have the edges of any part of the 
wound separated?” was not specific enough for measuring 
the intended construct (cases where the wound had spon-
taneously broken down or ‘dehisced’). Specifically, the 
item was being interpreted too broadly by both patients 
and HCPs and was therefore interpreted to overlap with 
another later intended to measure the deliberate separa-
tion of the wound edges by a doctor or nurse (“Has your 
wound been reopened by a doctor or nurse?”’) (box 6). 
A medical term (‘spontaneous dehiscence’) was added 
to this item and the plain language revised to “Have the 
edges of any part of the wound separated on their own 
accord”. Subsequent interviews with HCPs indicated 
that, had this medical term not been included, the plain 
language alone may not have been interpreted to include 
more serious cases of wound breakdown.
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box 5 Improved content validity of the construct to be 
measured
Item: Has your wound been cleaned out? (debridement of wound)
Participant: “[reading] ‘Has your wound been cleaned out?’… Yes it 
has been cleaned out…with this little plastic thing of liquid… saline 
stuff… They squirt this liquid in… put it on some gauze.” Patient 
participant, 1083
Participant: “I think… urm… when I had the staples taken out I 
think it was pretty standard practice for the nurse to just clean the 
wound before.… I don’t know what she put on but it was a bit of 
cotton wool and she just rubbed… something.” Patient participant, 
1104
Participant: “To me… cleaned out and debridement… isn’t the 
same thing. Cleaned out is washing with saline and debridement 
is picking… slough… like yellow stuff out… or cutting dead skin 
away or scabs.” Healthcare professional participant, 3000
Participant: “When you say cleaning out of the wound do you just 
mean, like, getting some water?…That [debridement] actually, to 
me, involves cutting… debridement is when you actually remove by 
cutting… or scraping… some dead tissue. Cleaned out, to me, just 
implies… oh, um, that you just gave it a bit of a clean… I complete-
ly understand what debridement of the wound means but, to me, 
cleaned out is not the same.” Healthcare professional participant, 
1142
Modified item: Has your wound been cleaned out to remove any dead 
tissue? (debridement of wound) draft version 6.0 10/04/2015
box 6 Improved content validity of the construct to be 
measured
Item: Have the edges of any part of the wound separated?
Participant: “So what does that one mean?… so… it is separated… 
because it’s not stitched up”… The actual wound was left open 
because they couldn’t stitch it up.” Patient participant, 1079
Participant: “What does that [separated] mean—like cut or some-
thing? Got bigger?” Patient participant, 1076
Modified item: Have the edges of any part of the wound separat-
ed on their own accord? (spontaneous dehiscence) draft version 2.0 
05/02/2015
DIsCussIOn
This article describes the novel concept of, and a method 
for developing, a UROM. This is a single questionnaire 
developed to measure a construct using data collected 
from either patients and/or HCPs by using a single set 
of terminology comprising both plain language and 
medical terminology. A UROM may be required for logis-
tical reasons (as in the example case study) or it may be 
for other purposes when there is a need to combine or 
compare responses from different stakeholders. Devel-
opment of a UROM includes established methods for 
developing new outcome measures,11 12 uniquely adapted 
to address specific considerations and requirements of 
a UROM. These considerations include incorporating 
the views of all key stakeholders in all phases of UROM 
development and a novel approach to item construc-
tion by combining plain language alongside medical 
terminology.
Illustrated within a case study of surgical wound assess-
ment, the findings from this study indicate UROMs are 
acceptable for completion by both patients and HCPs 
and ready for further evaluation in future work. An unan-
ticipated secondary finding of the study was that the 
combined use of plain language and medical terminology 
during questionnaire development may be a useful, 
novel technique for evaluating item interpretation and 
thereby identify items with inadequate content validity. 
Development and use of a UROM is recommended for 
studies where it is appropriate and beneficial to measure 
a construct using data collected from either patients and/
or HCPs.
The concept of a UROM, with items that combine 
plain language and medical terminology, represents a 
different approach to outcome measurement where 
traditionally tools for patients and HCPs are devel-
oped separately and used separately. Guidelines for 
the development of measurement instruments usually 
advise against the use of clinical or technical jargon (eg, 
medical terminology), particularly when the general 
public are the intended recipients.12 20 In general, 
guidance recommends not to use medical terminology 
in patient literature to avoid any difficulty in under-
standing.20–22 This study shows, however, that the use of 
medical terminology alongside plain language during 
the development of a measurement instrument can 
be beneficial for making sure items are interpreted 
as intended and reflect the intended construct to be 
measured. No patients in this study reported concerns 
with this approach.
To our knowledge, this is the first study to introduce and 
examine the concept of a UROM. The use of this method 
for ensuring content validity may be applicable and bene-
ficial in a wider context. Within our research institution, 
for example, we have undertaken studies developing core 
outcome sets (COSs) for trials in oesophageal, colorectal 
and bariatric surgery where the views of patients and HCPs 
on the same subject were required.23–25 A UROM, with 
items written in plain language and medical terminology 
in parentheses where appropriate, was used to collect 
the opinions of both patients and HCPs and prioritise 
outcomes of importance.23–25 This concept is now recom-
mended to COS developers as one approach to consider 
for describing outcomes to stakeholder groups.26 Other 
potential advantages of using UROMs rather than sepa-
rate questionnaires for patients and HCPs include: (1) 
the need for a single study to develop the tool rather than 
separate studies for patient and HCPs measures; (2) a 
more streamlined and efficient way of collecting outcome 
data, with easier administration and reduced costs by 
using the same measure and (3) ease of data synthesis 
as data from multistakeholders can be readily combined. 
Further work to examine the applicability of UROMs to 
different settings would be beneficial.
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This study has several strengths. It is the first study, 
to our knowledge, to describe a UROM; an outcome 
measure intentionally developed for patient and health-
care professional completion. One-to-one cognitive inter-
views with patients and HCPs also allowed for a detailed 
examination of item comprehension and acceptability 
of a single tool combining plain language and medical 
terminology in both stakeholder groups. UROMs are a 
novel concept and, currently, their evaluation is limited 
to the findings from this single case study. The potential 
advantages of the UROM design for improving content 
validity identified in this study was an unanticipated 
finding, however, and was not a primary focus of the case 
study interviews. The number of direct examples for its 
evaluation are, consequently, limited. The exact extent 
and nature to which medical terminology influences 
participants’ responses warrants further investigation. 
In box 4, for instance, it is assumed that the respondent 
was clearer or more accurate with their response as a 
direct result of reading the medical term. The possibility 
that the medical term may have introduced uncertainty, 
‘noise’ or measurement error was not formally explored. 
The detailed validation of the SSI outcome measure and 
the accuracy of the tool for assessing wound infection 
has been reported in full elsewhere14, however, did not 
explore this possibility.
In summary, a novel approach to outcome assessment 
and development of a UROM is described. Findings 
have shown that combining plain language and medical 
terminology within items can improve content validity. 
It is a recommended technique for the development of 
outcome measures in other situations where information 
from both patients and HCPs is required. Further work 
is now needed to explore the applicability of UROMs 
in other settings within and outside the field of surgical 
research.
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